N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)

Clinical trial NCT03759678 · TERMINATED

Trial details

NCT number: NCT03759678
Sponsor: IntraBio Inc
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Ataxia Telangiectasia

Start date: 2020-01-08
Primary completion: 2025-02-11
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.